AnaptysBio, Inc. ANAB Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s total current liabilities?
- AnaptysBio, Inc. (ANAB) reported total current liabilities of $41.7M in Q1 2026.
- How has AnaptysBio, Inc.'s total current liabilities changed year-over-year?
- AnaptysBio, Inc.'s total current liabilities decreased by 5.3% year-over-year, from $44.04M to $41.7M.
- What is the long-term trend for AnaptysBio, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s total current liabilities has grown at a 14.3% compound annual growth rate (CAGR), from $19.82M to $38.63M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.